RT Journal Article
SR Electronic
A1 Alexander, Lori
T1 Enoxaparin Continues to Show Clinical Benefit Vs Unfractionated Heparin for STEMI
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 5
SP 11
OP 11
DO 10.1177/155989770700700506
UL http://mdc.sagepub.com/content/7/5/11.abstract
AB One-year results of the ExTRACT-TIMI 25 trial continued to show significant benefits in favor of adjunctive treatment with enoxaparin vs unfractionated heparin in reducing the rate of death or nonfatal myocardial infarction in 20,479 patients with ST-elevation myocardial infarction treated with fibrinolysis.